Long-Term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients With Centrally Located Thoracic Tumors: SABR for Central Thoracic Tumors. Radiol Oncol [Internet]. 2020 Nov. 13 [cited 2026 Sep. 22];54(4):480-7. Available from: https://radioloncol.com/index.php/ro/article/view/3439